Cargando…

Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk

BACKGROUND: Diffusion-weighted (DW)-MRI is invaluable in detecting prostate cancer. We determined its sensitivity and specificity and established interobserver agreement for detecting tumour in men with a family history of prostate cancer stratified by genetic risk. METHODS: 51 men with a family his...

Descripción completa

Detalles Bibliográficos
Autores principales:	deSouza, Nandita M., Morgan, Veronica A., Bancroft, Elizabeth, Sohaib, S. Aslam, Giles, Sharon L., Kote-Jarai, Zsofia, Castro, Elena, Hazell, Steven, Jafar, Maysam, Eeles, Rosalind
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687444/ https://www.ncbi.nlm.nih.gov/pubmed/26779560 http://dx.doi.org/10.1016/j.ejro.2014.08.002

Ejemplares similares

Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups
por: McHugh, Jana, et al.
Publicado: (2021)

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
por: Castro, Elena, et al.
Publicado: (2016)

Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease
por: Saunders, Edward J., et al.
Publicado: (2021)

Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI
por: Winfield, Jessica M., et al.
Publicado: (2016)

Preoperative imaging in patients undergoing trachelectomy for cervical cancer: Validation of a combined T2- and diffusion-weighted endovaginal MRI technique at 3.0 T
por: Downey, Katherine, et al.
Publicado: (2014)

LocusExplorer: a user-friendly tool for integrated visualization of human genetic association data and biological annotations
por: Dadaev, Tokhir, et al.
Publicado: (2016)

Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls
por: Locke, Imogen, et al.
Publicado: (2007)

Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer
por: Hansen, Emma B., et al.
Publicado: (2023)

Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique
por: Downey, K, et al.
Publicado: (2013)

BRCA1, BRCA2 and their possible function in DNA damage response
por: Kote-Jarai, Z, et al.
Publicado: (1999)

Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status
por: Killick, Emma, et al.
Publicado: (2014)

Distortion correction of echo‐planar diffusion‐weighted images of uterine cervix
por: deSouza, Nandita M., et al.
Publicado: (2015)

Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI
por: Harvey, Hugh, et al.
Publicado: (2017)

Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate
por: Basharat, Meer, et al.
Publicado: (2014)

Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions
por: Mancuso, Nicholas, et al.
Publicado: (2019)

Large-scale transcriptome-wide association study identifies new prostate cancer risk regions
por: Mancuso, Nicholas, et al.
Publicado: (2018)

Accurate prediction of BRCA1 and BRCA2 heterozygous genotypes using expression profiling of lymphocytes after irradiation-induced DNA damage
por: Kote-Jarai, Z, et al.
Publicado: (2008)

Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)
por: Alexander, E.J., et al.
Publicado: (2019)

Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men
por: Killick, Emma, et al.
Publicado: (2013)

Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk
por: Bancroft, Elizabeth K., et al.
Publicado: (2021)

Diffusion-weighted MR imaging of metastatic abdominal and pelvic tumours is sensitive to early changes induced by a VEGF inhibitor using alternative diffusion attenuation models
por: Orton, Matthew R., et al.
Publicado: (2015)

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
por: Callender, Tom, et al.
Publicado: (2019)

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT
por: Ahmed, Mahbubl, et al.
Publicado: (2019)

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants
por: Dias, Alexander, et al.
Publicado: (2023)

Homeobox B13 G84E Mutation and Prostate Cancer Risk
por: Nyberg, Tommy, et al.
Publicado: (2019)

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening
por: Benafif, Sarah, et al.
Publicado: (2021)

Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]
por: Bancroft, Elizabeth K., et al.
Publicado: (2015)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer
por: Nyberg, Tommy, et al.
Publicado: (2023)

MR guided high intensity focused ultrasound (MRgHIFU) for treating recurrent gynaecological tumours: a pilot feasibility study
por: Giles, Sharon L, et al.
Publicado: (2019)

Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer
por: Downey, Kate, et al.
Publicado: (2015)

Prediction of pelvic tumour coverage by magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) from referral imaging
por: Lam, Ngo Fung Daniel, et al.
Publicado: (2020)

Modelling DW-MRI data from primary and metastatic ovarian tumours
por: Winfield, Jessica M., et al.
Publicado: (2015)

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers
por: Kadouri, L, et al.
Publicado: (2008)

Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease
por: Mijuskovic, Martina, et al.
Publicado: (2018)

Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease
por: Mijuskovic, Martina, et al.
Publicado: (2019)

Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study
por: Aladwani, Mohammad, et al.
Publicado: (2020)

Men with a susceptibility to prostate cancer and the role of genetic based screening
por: Eeles, Rosalind, et al.
Publicado: (2018)

How can we recruit more men of African or African-Caribbean ancestry into our research? Co-creating a video to raise awareness of prostate cancer risk and the PROFILE study
por: Hainsworth, Emma, et al.
Publicado: (2022)

MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423)
por: Jackson, Alan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5sbrpu9drdpq3luo6mp2jtfjon